Joern Aldag's Insider Trades & SAST Disclosures
Joern Aldag's most recent trade in Hookipa Pharma Inc was a trade of 971,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joern Aldag.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 971,400 | 971,400 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 07 Jul 2023 | 5,000 | 71,952 (0%) | 0% | 0.8 | 4,142 | Common Stock |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 07 Jul 2023 | 5,000 | 66,952 (0%) | 0% | 0.8 | 4,050 | Common Stock |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 05 Jul 2023 | 5,000 | 61,952 (0%) | 0% | 0.9 | 4,450 | Common Stock |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 03 Jul 2023 | 5,000 | 56,952 (0%) | 0% | 0.9 | 4,456 | Common Stock |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 513,600 | 513,600 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 275,250 | 275,250 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 275,250 | 275,250 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 01 Feb 2022 | 47,824 | 51,952 (0%) | 0% | 3 | 143,472 | Common Stock |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 39,853 | 39,853 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 207,600 | 207,600 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2020 | 4,128 | 4,128 (0%) | 0% | 0 | Common Stock | |
| Cogent Biosciences Inc | Joern Aldag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 40,090 | 40,090 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Joern Aldag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 14,331 | 14,331 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Joern Aldag | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2020 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Joern Aldag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2020 | 56,690 | 56,690 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges